Access 2.8M+ Filings Sign Up Free
Spexis AG Logo

Spexis AG | SPEX - Profile, Filings, Stock Info & Investor Relations Data

Spexis AG | SPEX
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Switzerland
Founded
1996
Spexis AG (SPEX)

Company Profile

Website
Investor Relations

About Spexis AG

Headquartered in Switzerland and Boston, two global biotech-hubs, our ambition is to develop Spexis into a leading biopharmaceutical company with a strategic focus on rare diseases, oncology and antimicrobial resistance. With a strong scientific core, our drug discovery and research efforts are led by our in house scientist via leveraging our discovery platforms in collaboration with top academic centers around the globe. We have two clinical programs focused on products for rare, chronic respiratory diseases.

Spexis AG is a combination of the two legacy companies, Polyphor, a publicly listed Swiss biotech and EnBiotix, a privately held US biotech. In December 2021, two companies – Polyphor and EnBiotix – teamed up to join forces and formed Spexis.

Employees

28

Market Presence

Worldwide

Headquarters

Hegenheimermattweg 125
4123, Allschwil
Switzerland

Spexis AG (SPEX)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Spexis AG (SPEX)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

◆
N/A (Executive member)
Other CHF 0.00 CHF 0.00 21.06.22

Spexis AG (SPEX)
Stock & Investor Information

ISINs

CH0106213793

LEI

391200S8HJE1I96FIG04

Stock Exchange Listings

SIX Swiss Exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology